Coya Therapeutics Inc. (COYA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Coya Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$4.06
−1.46% today
Market cap
$97M
Overall quality
55/100
Kronos AI 30-day
+16.3%
8 of 8 simulated paths end higher
Coya Therapeutics Inc. (COYA) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $97M. It trades at $4.06, down 1.46% today. Its overall quality score is 55 out of 100, ranked against the whole US market. 4 analysts' average target of $15.75 implies +287.9% from today's price. Kronos AI's 30-day forecast is +16.3% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $15.75 |
| Low – high | $12.00 – $18.00 |
| Analysts | 4 |
| Upside to average | +287.9% |
Kronos AI 30-day forecast
| Expected close | $4.79 (+16.3%) |
| Likely range | +11.1% … +20.1% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 11 |
| Solvency | 90 |
| Growth | 64 |
| Overall | 55 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.